ArticleMycotoxin research2025
Protective effect of organic selenium and organic chromium dietary supplementation against aflatoxicosis in mice.
Article in Mycotoxin research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aflatoxins are highly toxic mycotoxins linked to serious health issues, including hepatotoxicity, immunosuppression, and oxidative stress. This study investigated the protective effects of chromium-methionine (Cr-Met) and selenium-methionine (Se-Met) supplementation, both alone and in combination, against aflatoxin-induced toxicity in mice. Five dietary treatments were implemented: a control diet (T1), an aflatoxin-contaminated diet containing 2 mg of aflatoxins per kg of diet (T2), and aflatoxin-contaminated diets supplemented with 0.5 mg of Cr-Met per kg (T3), 0.5 mg of Se-Met per kg (T4), or a combination of both (T5). Exposure to aflatoxins significantly (p < 0.05) impaired growth performance, disrupted liver enzyme profiles, suppressed immune function, and compromised antioxidant defense mechanisms. In contrast, dietary supplementation with T3 and T4 markedly (p < 0.05) enhanced growth performance, increased feed intake, and elevated immunoglobulin levels while reducing oxidative stress markers and liver damage. Gene expression analysis indicated that aflatoxin exposure led to the upregulation of inducible nitric oxide synthase (iNOS) and the downregulation of catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx); supplementation effectively reversed these alterations. Notably, the combined supplementation (T5) demonstrated the most significant protective effects, suggesting the role of chromium and selenium in alleviating aflatoxin-induced toxicity (p < 0.05). These findings underscore the potential of using Cr-Met and Se-Met in combination as effective dietary strategies to mitigate aflatoxin toxicity and enhance antioxidant and immune responses.
Indexed as
Identifiers
41296112What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.